Healthcare Services

Open-Angle Glaucoma (OAG) Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Open-Angle Glaucoma (OAG) Market From 2026 To 2030?

The open-angle glaucoma (oag) market has demonstrated robust growth over recent years. Its size is projected to expand from $6.53 billion in 2025 to $6.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. Historically, this expansion was driven by factors such as limited access to in-person mental health services, a rising prevalence of anxiety and depression, increased awareness regarding the importance of mental health, the growing utilization of early telemedicine platforms, and the early adoption of online counseling programs.

The open-angle glaucoma (OAG) market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $8.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This growth during the forecast period can be attributed to an escalating demand for accessible online therapy, the increasing adoption of mobile and web-based counseling tools, the growing integration of AI-powered mental wellness solutions, a rising utilization of hybrid therapy models combining individual and group sessions, and the expansion of online therapy offerings in commercial and residential segments. Significant trends within this period include the rising adoption of prostaglandin analog drugs, the increasing use of minimally invasive glaucoma surgeries, growing awareness about early diagnosis and screening, a rise in teleophthalmology consultations for OAG management, and the increasing development of combination drug therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Major Drivers Are Influencing Demand In The Open-Angle Glaucoma (OAG) Market?

The rising understanding of eye-related ailments is set to advance the open-angle glaucoma (OAG) market in the future. Eye illnesses encompass various medical conditions that affect the structure, operation, or visual capacity of the eyes, varying from minor issues like dry eye to serious disorders such as glaucoma and macular degeneration. Their occurrence is escalating due to factors such as an aging global populace, prolonged exposure to screens, a rise in diabetes cases, environmental pollutants, and lifestyle choices that compromise eye health. Open-angle glaucoma (OAG), a primary contributor to blindness, particularly among older individuals, underscores the vital importance of consistent eye examinations, prompt diagnosis, and proactive therapeutic interventions to avert permanent vision impairment. A notable example, provided in October 2023 by the Royal National Institute of Blind People (RNIB), a UK-based charity focused on sight loss, revealed that eye care outpatient appointments in the UK surpassed eight million in 2021/22, establishing it as the most sought-after medical specialty. Furthermore, the population affected by sight loss, currently exceeding two million, is projected to double to over four million by 2050. Consequently, the increasing awareness of eye illnesses is a key catalyst for growth within the open-angle glaucoma (OAG) market.

Which Segments Are Included In The Analysis Of The Open-Angle Glaucoma (OAG) Market?

The open-angle glaucoma (oag) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

What Key Trends Are Influencing The Development Of The Open-Angle Glaucoma (OAG) Market?

Leading companies active in the open-angle glaucoma (OAG) market are prioritizing the creation of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to deliver advanced and less intrusive options for managing primary open-angle glaucoma, reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) describes a variety of surgical implants and techniques developed to decrease intraocular pressure in glaucoma patients using small incisions and minimal disturbance to ocular tissues. For example, in December 2023, iSTAR Medical, a medtech company from Belgium, introduced MINIject in the Netherlands. This bio-integrating therapy for primary open-angle glaucoma leverages a distinctive porous STAR material to improve fluid outflow and reduce IOP. By lessening dependence on conventional therapies, MINIject signifies a considerable advancement in glaucoma care, providing a safer and more efficient management choice for this principal cause of permanent blindness.

Which Key Industry Participants Are Active In The Open-Angle Glaucoma (OAG) Market?

Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.

Read the full open-angle glaucoma (oag) market report here:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Open-Angle Glaucoma (OAG) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2026, By The Business Research Company

Onychomycosis Global Market Report

https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report

Yeast Infection Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report

Aspergillosis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/aspergillosis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795